(Q34543412)

2 August 2017

1 reference

title

Polyglutamine disease: acetyltransferases awry (English)

1 reference

2 August 2017

Robert E Hughes

1

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

2 August 2017

1 reference

2 August 2017

volume

12

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

R141-3

1 reference

Glutamine repeats and neurodegeneration

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900709-1

7 January 2021

Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900709-1

7 January 2021

Transcriptional dysregulation in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900709-1

7 January 2021

Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900709-1

7 January 2021

CAG repeat expansion in the TATA box-binding protein gene causes autosomal dominant cerebellar ataxia.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900709-1

7 January 2021

Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900709-1

7 January 2021

CREB-binding protein sequestration by expanded polyglutamine

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900709-1

7 January 2021

The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900709-1

7 January 2021

Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900709-1

7 January 2021

Polyglutamine and CBP: fatal attraction?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900709-1

7 January 2021

Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein-Taybi syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900709-1

7 January 2021

Histone deacetylase inhibitors reduce polyglutamine toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900709-1

7 January 2021

Histone deacetylase inhibitors as new cancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900709-1

7 January 2021

Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900709-1

7 January 2021

Altered transcription in yeast expressing expanded polyglutamine

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900709-1

7 January 2021

Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900709-1

7 January 2021

Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900709-1

7 January 2021

Decreased expression of striatal signaling genes in a mouse model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900709-1

7 January 2021

10.1016/S0960-9822(02)00709-1

Identifiers

DOI

1 reference

2 August 2017

1 reference